IL33 and neoplasm: Maintaining immunosuppression functions in the tumour milieu, presence of IL-33 increased TGF-β1 producing MDSCs and reduced IFN-γ expressing NKp46 + tumour lysing cells (Martini et al., 2010; Jovanovic et al., 2014).